SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.
暂无分享,去创建一个
Daoud Meerzaman | Junya Fukuoka | Jin Jen | W. Travis | J. Jen | K. Shilo | T. Dracheva | H. Jeon | D. Meerzaman | J. Fukuoka | S. Yang | William D Travis | Sei-Hoon Yang | Hyo-Sung Jeon | Konstantin Shilo | A. Shakoori | Tatiana Dracheva | Abbas Shakoori
[1] M. Reiss,et al. A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression. , 1996, Cancer research.
[2] C. Heldin,et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.
[3] K. Miyazono,et al. Divergence and convergence of TGF‐β/BMP signaling , 2001, Journal of cellular physiology.
[4] T. Waldman,et al. Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells , 2004, Cancer biology & therapy.
[5] H. Friess,et al. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.
[6] S. Park,et al. Smad6 negatively regulates interleukin 1-receptor–Toll-like receptor signaling through direct interaction with the adaptor Pellino-1 , 2006, Nature Immunology.
[7] Jennifer Lee,et al. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. , 2003, Cancer research.
[8] R. Weinberg,et al. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[9] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[10] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[11] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[12] Xin-Hua Feng,et al. Smad6 Recruits Transcription Corepressor CtBP To Repress Bone Morphogenetic Protein-Induced Transcription , 2003, Molecular and Cellular Biology.
[13] R. Derynck,et al. TGF-beta signaling in cancer--a double-edged sword. , 2001, Trends in cell biology.
[14] K. Miyazono,et al. Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.
[15] J. Massagué,et al. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.
[16] R. Davis,et al. Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.
[17] J. Harbour,et al. Rb function in cell-cycle regulation and apoptosis , 2000, Nature Cell Biology.
[18] H. Kuwano,et al. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma. , 2004, Anticancer research.
[19] R. Derynck,et al. TGF-β signaling in cancer – a double-edged sword , 2001 .
[20] J. Wrana,et al. The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.
[21] R. Weinberg,et al. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. , 1988, Science.
[22] Y. Yatabe,et al. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells , 1998, Oncogene.
[23] J. Massagué,et al. TGF- SIGNAL TRANSDUCTION , 1998 .
[24] Ester Piek,et al. Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .
[25] M. Sporn,et al. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Weiss,et al. Smad6 Represses Dlx3 Transcriptional Activity through Inhibition of DNA Binding* , 2006, Journal of Biological Chemistry.
[27] A. Näär,et al. A component of the ARC/Mediator complex required for TGFβ/Nodal signalling , 2002, Nature.
[28] M. Laiho,et al. Transforming growth factor‐beta is a strong and fast acting positive regulator of the level of type‐1 plasminogen activator inhibitor mRNA in WI‐38 human lung fibroblasts. , 1987, The EMBO journal.
[29] K. Mohammad,et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.
[30] K. Miyazono,et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. , 2005, Journal of the National Cancer Institute.
[31] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[32] Y. Bang,et al. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer , 1999, Oncogene.
[33] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[34] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[35] C. Osborne,et al. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells , 1988 .
[36] Ravi Kiran Reddy Kalathur,et al. Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cells , 2007, BMC Genomics.
[37] M. Washington,et al. Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker. , 1996, Lung cancer.
[38] L. Attisano,et al. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] K. Miyazono,et al. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling , 2001, The Journal of cell biology.
[40] 福岡 順也. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer , 2004 .